Solved

How would you propose to elucidate and validate the role of secreted Frizzled related protein 2 (sFRP2) in the context of lung or skin fibrosis whereby sFRP2 may either lead to disease progression or inhibition of resolution?

Franziska Elena Herrmann

Franziska Elena Herrmann 
Principal Scientist 
Boehringer Ingelheim

No solution found

How do you propose improving the understanding of the role of natural killer cells in the progression of Systemic Sclerosis using novel disease relevant human cellular systems?

Preethi Vijayaraj

Preethi Vijayaraj 
Principal Scientist 
Boehringer Ingelheim

Solved

Applying high-throughput experimentation (HTE), how would you propose to screen and optimize chemical reactions under controlled mechanochemical conditions to avoid using dipolar aprotic solvents?

Access funding of up to USD 80,000.

Marco Santagostino

Marco Santagostino 
Senior Principal Scientist 
Boehringer Ingelheim

Latest active call

double helix
23

GPR149 in psychiatric symptoms and obesity

Using suitable model systems, how would you propose to elucidate and validate the molecular role of GPR149 in symptoms related to mental health and obesity?

Collaborate with us

Hear from our collaborators

As an academic postdoc, opnMe provided me with the opportunity to apply my skills in a "semi-industry" setting. Collaborating with Boehringer Ingelheim’s experts on pharmacologically relevant questions in neuroscience was particularly exciting, as it aligns with my deep passion for the field.

Senior Research Fellow, Temasek Life Sciences Laboratory, Singapore

opnMe's expert guidance was pivotal in forging our research collaboration with Boehringer Ingelheim. Their initiative seamlessly bridged the gap between academic and industry research, uniting foundational biomedical science with application-oriented translational animal health research.

Associate Professor, City University of Hong Kong

With the help of opnMe, we teamed up with Boehringer Ingelheim to develop a human-in-the-loop AI solution for pre-clinical research. We’re excited to see the tool in active use, having a measurable positive impact on the daily work of the scientists and increasing the safety of drug discovery.

CTO, Merantix Momentum GmbH, Berlin

opnMe represents a great concept of open science in two ways: It allows Boehringer to stimulate research at the forefront of scientific discovery within a well-defined disease area and it allows academics to excel by approaching Boehringer Ingelheim with proactive, innovative ideas.

Vice President Research, ETH Zurich

I found the opnMe portal very easy to navigate and use. The application process is straightforward; this can be achieved in one afternoon. The time from submission to decision is one of the fastest turnarounds I have had, and this aspect makes a real difference in the momentum of pursuing a scientific idea.

Associate Professor, University College London

opnMe facilitated an efficient research partnership with Boehringer Ingelheim, accelerating the discovery of bioactive peptides. opnMe enabled us to combine expertise and resources, therefore leveraging the strengths of both organizations to achieve innovative outcomes.

CMO, PXBioVisioN GmbH, Hannover

It has been a pleasure for me to participate in opnMe. In addition to providing funding for our research project, it has given my lab an opportunity to collaborate with excellent people at Boehringer Ingelheim, generated some exciting results, and taught us new things about brain circuitry.

Senior Investigator, Temasek Life Sciences Laboratory, Singapore